glp-1 news today october 23 2025 How the rise of drugs is shifting consumer habits ISPOR 2025: Exploring reasons for
Description
In clinical trials of GLP-1 medications, adults lost a mean of roughly 15% of body weight over about a year (STEP-1, Novo Nordisk
The survey was performed during April and May of 2025
Cardiovascular Exercise Guidelines Include some form of cardiovascular activity most days of the week
In the first trial, liraglutide lowered weight by 12 pounds and improved glucose tolerance relative to placebo over 4 months in 103 patients with schizophrenia spectrum disorders (Larsen JR et al, JAMA Psych 2017;74(1):719728)
Norman, A.W
For this reason, the relevant current international guidelines include these two drug classes for patients with a corresponding risk profile
